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Four  studies  were  conducted  to examine  the  efﬁcacy  of  a novel  topical  combination  of
ﬁpronil,  (S)-methoprene,  eprinomectin,  and  praziquantel  (BROADLINE®, Merial)  against
Ancylostoma  tubaeforme  and  Ancylostoma  braziliense  hookworms  of  cats.  In  each  study,
purpose-bred  cats were  randomly  assigned  to treatment  groups  of  10 or  12 cats  per group.
In three  studies  the  cats  were  inoculated  with  A.  tubaeforme  and  in  one  study  with A.
braziliense.  The  inoculations  were undertaken  on  a schedule  which  resulted  in the hook-
worms  reaching  the fourth  larval  stage  in  two  of  the studies,  or the  adult  stage  in four  of the
studies, by the  day  of treatment.  In each  study  there  was  also  an  untreated  control  and  1 or
2 groups  treated  with  the  novel  combination.  In the two studies  where  efﬁcacy  against  the
fourth larval  stage  of  A.  tubaeforme  was  tested,  the  efﬁcacy  recorded  was  100%.  In  the  three
studies where  efﬁcacy  against  the adult stage  of A. tubaeforme  was  tested,  efﬁcacy  of  100%
was also  conﬁrmed.  In the  study  where  efﬁcacy  against  the  adult  stage  of A.  braziliense  was
tested  efﬁcacy  was  99.5%.
© 2014  The  Authors.  Published  by  Elsevier  B.V.  This  is an  open  access  article  under  the  CC
BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Ancylostoma tubaeforme is a common hookworm of
cats found worldwide; Ancylostoma braziliense is found
in coastal areas of the Americas and Africa. Cats can be
infected with both of these species either by ingesting third
stage larvae or by the larvae penetrating the skin (Bowman
et al., 2002). Rodents can serve as paratenic hosts and pre-
dation by cats of infected rodent can result in infection
(Norris, 1971).
∗ Corresponding author. Tel.: +1 573 642 5977; fax: +1 573 642 0356.
E-mail address: joseph.prullage@merial.com (J.B. Prullage).
http://dx.doi.org/10.1016/j.vetpar.2014.02.035
0304-4017/© 2014 The Authors. Published by Elsevier B.V. This is an open acce
licenses/by-nc-nd/3.0/).Infection with A. tubaeforme causes signiﬁcant blood
loss from the small intestinal mucosa and is associated with
weight loss, regenerative anemia and, in heavy infections,
can be lethal. During the larval migration, respiratory clini-
cal signs including dyspnea and coughing can be observed,
as it is with Toxocara cati. Because of the clinical signiﬁcance
of infections with A. tubaeforme, treatment is important to
maintain the health of the cat. A. braziliense infects both
cats and dogs and does not commonly cause signiﬁcant
enough blood loss to result in disease in either host species
(Bowman et al., 2002). A. braziliense is probably the major
cause of cutaneous larva migrans in humans. The majority
of cases of cutaneous larva migrans overlap with the distri-
bution of A. braziliense and are not as commonly associated
ss article under the CC BY-NC-ND license (http://creativecommons.org/
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with the distribution of other species of Ancylostoma and
Uncinaria (Bowman et al., 2010). Because of the zoonotic
potential of A. braziliense it is important to deworm the
domestic carnivores, acting as a source of eggs.
Eprinomectin is known to be effective against numer-
ous endoparasites of ruminants and therefore has shown
its effectiveness against a broad range of nematode para-
sites (Shoop et al., 1996a,b; Rehbein et al., 2012). This
paper reports the results of the ﬁrst studies demonstrating
the effectiveness of Broadline®, the novel topical endec-
tocide for cats containing eprinomectin, for the treatment
and control of the two most common Ancylostoma species
infecting cats in the Americas and Europe.
2. Materials and methods
The study designs were generally in accordance
with the International Cooperation on Harmonisation
of Technical Requirements for Registration of Veteri-
nary Medicinal Products-VICH (International harmoni-
sation of anthelmintic efﬁcacy guidelines), “Efﬁcacy of
Anthelmintics: General Requirements” GL7 (Vercruysse et
al., 2001) and “Efﬁcacy of Anthelmintics: Speciﬁc Rec-
ommendations for Felines” VICH GL20 (Vercruysse et al.,
2002); and the “World Association for the Advancement of
Veterinary Parasitology (WAAVP) guidelines for evaluating
the efﬁcacy of anthelmintics for dogs and cats” (Jacobs et
al., 1994). All cats were purpose-bred for laboratory studies
and were handled with due regard for their welfare and in
compliance with Merial Institutional Animal Care and Use
Committee approvals and applicable local regulations.
Four induced infection studies were conducted to con-
ﬁrm the effectiveness of the novel combination against
hookworms, three studies with A. tubaeforme and one study
with A. braziliense.
2.1. Experimental animals
Treatment groups consisted of 10 cats per group in stud-
ies 1, 2, 4 and 12 cats per group study 3. For evaluation of
efﬁcacy against fourth stage larvae of A. tubaeforme cats
were inoculated 7 days prior to treatment and for evalua-
tion of efﬁcacy against adult A. tubaeforme or A. braziliense
cats were inoculated 21 days or more prior to treatment
(details provided in Table 1). Cats had not been treated
with any anthelmintic for at least 4 weeks prior to the ﬁrst
inoculation of parasites.
2.2. Experimental infection
All cats were inoculated orally with a suspension of
infective third stage larvae. A. tubaeforme was  obtained
from isolates maintained at the laboratory for studies 1,
2, and 4. The isolates had been maintained in the labo-
ratory for less than 3 years for study 1 and less than 1
year for studies 2 and 4. The A. tubaeforme used for study
3 was obtained by hatching eggs collected from naturally
infected cats. The parasites were recent isolates originating
from both the USA (A. braziliense and A. tubaeforme) and
Europe (A. tubaeforme) (Table 1). Eighteen of the twenty
cats in study 4 vomited within 1 h of inoculation with
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Table 2
Parasite counts and therapeutic efﬁcacy of Broadline® against different developmental stages of experimentally induced Ancylostoma tubaeforme and
Ancylostoma braziliense in cats.
Study Species Treatment Target stage Number of cats infected/number of
cats in group
Geometric meana
(range)b
Percent
efﬁcacyc
P-valued
1 A. tubaeforme Untreated – 10/10 45.13 (2–129) – –
Treated L4 0/10 0.0 100% <0.001
Treated Adult 0/10 0.0 100% <0.001
2 A.  tubaeforme Untreated – 10/10 69.1 (3–152) – –
Treated L4 0/10 0.0 100% <0.001
Treated Adult 0/10 0.0 100% <0.001
3 A.  tubaeforme Untreated – 12/12 54.8 (21–125) – –
Treated Adult 0/12 0.0 100 <.001
4 A.  braziliense Untreated – 10/10 137.0 (49–339) – –
Treated Adult 6/10 0.6 (0–2) 99.5 <.001
a Geometric mean counts based on transformation of ln (count + 1).
b Range is for total nematode counts.
c Percent efﬁcacy = 100 × [(C − T)/C], where C = geometric means of the untreated control and T = geometric mean of the treated group.
ated grod Two-sided P-value comparing the population worm burden of the tre
A. braziliense and were re-inoculated with approximately
300 third stage larvae. These re-inoculations were done
to insure there were sufﬁcient parasites present on the
day of treatment for valid evaluations of efﬁcacy. In study
1 each cat was also inoculated orally on Day 5 prior to
treatment with approximately 300 and 200 infective Tox-
ocara cati eggs, respectively (results of the T. cati infections
are not shown here but are published by Knaus et al.,
2014b).
2.3. Experimental design
Cats were ranked in descending order by pre-treatment
body weights and assigned to 10 blocks of 3 cats each for
studies 1 and 2; 12 blocks of 2 cats each for study 3; and 10
blocks of 2 cats each for study 4. Within blocks, cats were
randomly allocated to treatments. In each study there was
one untreated control group and 1 or 2 groups treated with
BroadlineTM. The concentrations of the actives in the com-
bination are: ﬁpronil 8.3% w/v, (S)-methoprene 10% w/v,
eprinomectin 0.4% w/v, praziquantel 8.3% w/v. Treatments
were applied at a dose volume of 0.12 mL  of the novel com-
bination per kilogram body weight, directly on the skin in
the midline of the neck, between the base of the skull and
the shoulder blades in a single spot. This resulted in appli-
cations of 10 mg/kg ﬁpronil, 12 mg/kg (S)-methoprene,
0.5 mg/kg eprinomectin, and 10 mg/kg praziquantel, the
intended minimum therapeutic dose. Treatments were
applied on study Days 0 or 14 as noted in Table 1. Body
weights were measured between 3 and 1 days prior to
treatment to calculate doses administered on study Day
0 and on study Day 13 to calculate doses administered
on study Day 14. Timing of the interval between inocu-
lation with A. tubaeforme and treatment with the novel
combination in studies 1 and 2 was designed so that the
parasites were expected to be fourth stage larvae on study
Day 0 or adults on study Day 14. In the remaining stud-
ies treatment days were timed to treat adult stages of
the parasite. All cats were observed hourly for 4 h after
treatment.ups with untreated control.
All cats were humanely euthanized for recovery of the
hookworms on the study day noted in Table 1. For all
studies the contents of the gastrointestinal tract (stom-
ach, small and large intestines including caecum) were
collected and washed through appropriate sized sieves to
collect the parasites. To collect any missing worms, the
gastrointestinal mucosae were then examined under mag-
niﬁcation and any parasites found were added to those
from the gastrointestinal contents. All parasites were iden-
tiﬁed to species and stage based on morphology and
counted.
2.4. Data analysis
Total counts of the parasites were transformed to the
natural logarithm of (count + 1) for calculation of geo-
metric means for each treatment group. Efﬁcacy for the
treated groups were calculated as the percent effective-
ness using the formula 100 × [(C − T)/C], where C is the
geometric mean among untreated controls and T is the
geometric mean among the treated cats. The log-counts
of the treated group were compared to the log-counts
of the untreated control group using a F-test adjusted
for the allocation blocks. The Mixed procedure in SAS®
Version 9.1.3 was used for this analysis with treatment
group as the ﬁxed effect and allocation blocks as the ran-
dom effect. Testing was two-sided at the signiﬁcance level
 ˛ = 0.05.
3. Results
No adverse experiences were noted during the four
hourly observations following treatment and during daily
health observations throughout the studies.
The geometric means of the nematode counts and per-
cent efﬁcacy for the novel combination are presented in
Table 2. In all studies, at least 6 cats in the untreated
control group had adequate infections of 20 or more A.
tubaeforme or 10 or more A. braziliense.  When compared
against the controls, cats treated with the novel combina-
tion had signiﬁcantly fewer A. tubaeforme and all 4 studies
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emonstrated efﬁcacy of 100% against the adult stage of
his parasite. Studies 1 and 2 demonstrated efﬁcacy of 100%
gainst the fourth stage larvae of A. tubaeforme.  The novel
ombination demonstrated efﬁcacy of 99.5% against adult
. braziliense.
. Discussion
The novel combination product appeared to be entirely
afe in these studies, as none of the 62 cats treated showed
ny adverse experience. The present studies have demon-
trated the efﬁcacy of the topical formulation of the product
gainst both A. tubaeforme and A. braziliense.
At the time of treatment, the hookworms were either
igrating L4 or intestinal adults, therefore no difference
n efﬁcacy would be expected between the oral infection
odel used here compared to a cutaneous infection that
ay occur in the ﬁeld.
This is the ﬁrst report of efﬁcacy of eprinomectin against
arval and adult hookworms in cats. Previous work has
emonstrated that eprinomectin is highly efﬁcacious when
dministered topically at 0.5 mg/kg against several species
f ruminant nematodes including Bunostomum phleboto-
um  the hookworm of cattle (Shoop et al., 1996a; Pitt
t al., 1997; Rehbein et al., 2012). A single previous study
as shown that eprinomectin may  be 100% efﬁcacious
gainst Toxocara canis in dogs at a dose of 0.1 mg/kg
rally (Kozan et al., 2008). The results of these studies
re also supported by the high efﬁcacy of 0.5 mg/kg epri-
omectin topically demonstrated against A. tubaeforme and
. braziliense in laboratory studies using naturally infected
ats treated with the novel combination (Knaus et al.,
014a). In addition, the combination was 100% efﬁcacious
gainst hookworms in a ﬁeld trial conducted in seven Euro-
ean countries (Rehbein et al., 2014).
Current recommendations for the control of A. tubae-
orme and A. braziliense infections in cats and humans
mphasize the importance of minimizing the exposure
o the infective stages of these parasites. An effective
eans of reducing the exposure of both humans and cats
s the use of effective anthelmintics to reduce the con-
amination of their environment with infective third stage
arvae. Because young cats are susceptible to recurrent
nfections with hookworms, regular monthly treatment is
ecommended (Gates and Nolan, 2009; http://www.
apcvet.org/capc-recommendations/hookworms/).
hether the infection was acquired orally or cuta-
eously the development to adult stages, as measured by
repatent period, is 28 days or less (Okoshi and Murata,
967; Bowman et al., 2002; Epe, 2009). The efﬁcacy
gainst fourth stage larvae provides a control when cats
re treated before the end of the prepatent period but also
llow a better prevention of lung lesions and respiratory
linical signs due to their migration.
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